MYC and myeloid sarcoma: Finally, the impairment of the glycolytic switch, pro-inflammatory cytokines and c-myc expression exerted by a selective inhibitor (Figure 5) evidenced a critical role of class 1A PI3K in regulating the glycolytic program of inflammatory T lymphocytes in MS.